Academic Journal

Cardiorespiratory Fitness (Peak Oxygen Uptake): Safe and Effective Measure for Cardiovascular Screening Before Kidney Transplant

التفاصيل البيبلوغرافية
العنوان: Cardiorespiratory Fitness (Peak Oxygen Uptake): Safe and Effective Measure for Cardiovascular Screening Before Kidney Transplant
المؤلفون: Harini A. Chakkera, Siddhartha S. Angadi, Raymond L. Heilman, Bruce Kaplan, Robert L. Scott, Harini Bollempalli, Stephen S. Cha, Hasan A. Khamash, Janna L. Huskey, Girish K. Mour, Sumi Sukumaran Nair, Andrew L. Singer, Kunam S. Reddy, Amit K. Mathur, Adyr A. Moss, Winston R. Hewitt, Ibrahim Qaqish, Senaida Behmen, Mira T. Keddis, Samuel Unzek, D. Eric Steidley
المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
بيانات النشر: Wiley, 2018.
سنة النشر: 2018
المجموعة: LCC:Diseases of the circulatory (Cardiovascular) system
مصطلحات موضوعية: function, ischemic heart disease, kidney, risk assessment, risk stratification, Diseases of the circulatory (Cardiovascular) system, RC666-701
الوصف: BackgroundSignificant heterogeneity exists in practice patterns and algorithms used for cardiac screening before kidney transplant. Cardiorespiratory fitness, as measured by peak oxygen uptake (VO2peak), is an established validated predictor of future cardiovascular morbidity and mortality in both healthy and diseased populations. The literature supports its use among asymptomatic patients in abrogating the need for further cardiac testing. Methods and ResultsWe outlined a pre–renal transplant screening algorithm to incorporate VO2peak testing among a population of asymptomatic high‐risk patients (with diabetes mellitus and/or >50 years of age). Only those with VO2peak 90%) negative predictive value, indicating that VO2peak ≥17 mL/kg per minute is effective to rule out future cardiac events and all‐cause mortality. However, lower VO2peak had low positive predictive value and should not be used as a reliable metric to predict future cardiac events and/or mortality. In addition, a simple mathematical calculation documented a cost savings of ≈$272 600 in the cardiac screening among our study cohort of 637 patients undergoing evaluation for kidney and/or pancreas transplant. ConclusionsWe conclude that incorporating an objective measure of cardiorespiratory fitness with VO2peak is safe and allows for a cost savings in the cardiovascular screening protocol among higher‐risk phenotype (with diabetes mellitus and >50 years of age) being evaluated for kidney transplant.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2047-9980
Relation: https://doaj.org/toc/2047-9980
DOI: 10.1161/JAHA.118.008662
URL الوصول: https://doaj.org/article/6e3869e7f60a40aaa8c0c0d155fd64a6
رقم الانضمام: edsdoj.6e3869e7f60a40aaa8c0c0d155fd64a6
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20479980
DOI:10.1161/JAHA.118.008662